• Explore /
  • Poster
  • / Multicenter retrospective analysis for efficacy and safety of liposomal irinotecan (nal-IRI) plus 5-FU/leucovorin (5-FU/LV) after progression on gemcitabine-based therapy in Korean patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A study by Korean cancer study group (KCSG).

Multicenter retrospective analysis for efficacy and safety of liposomal irinotecan (nal-IRI) plus 5-FU/leucovorin (5-FU/LV) after progression on gemcitabine-based therapy in Korean patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A study by Korean cancer study group (KCSG).

Abstract Poster

Authors

null

Changhoon Yoo

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Changhoon Yoo , Hyeon-Su Im , Kyu-Pyo Kim , Do-Youn Oh , Kyung-Hun Lee , Hong Jae Chon , Joo Hoon Kim , Myoung Joo Kang , Il-Hwan Kim , Guk Jin Lee , Sung Yong Oh , Younak Choi , Hye Jin Choi , Seung Tae Kim , Joon Oh Park , Baek-Yeol Ryoo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 344)

DOI

10.1200/JCO.2019.37.4_suppl.344

Abstract #

344

Poster Bd #

J2

Abstract Disclosures

Similar Posters

First Author: Li-Tzong Chen

First Author: Hans Prenen

First Author: Sherise C. Rogers

First Author: Takashi Imajima